Related Experiment Video
Updated: May 16, 2026
04:59
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Nonsteroidal, nonimmunosuppressive therapies for pruritus
1Allergy, Skin, and Ear Clinic for Pets, 31205 Five Mile, Livonia, MI 48154, USA. dermdoc@cvm.msu.edu
The Veterinary Clinics of North America. Small Animal Practice
|November 28, 2012
Summary
Pruritus, or itch, is a common symptom in dogs with many causes. Effective treatment requires a systematic approach to identify and resolve the underlying issues, enhancing therapeutic success.
Area of Science:
- Veterinary Dermatology
- Animal Science
Background:
- Pruritus, commonly known as itch, is a complex sensation often leading to scratching.
- It is a prevalent symptom in veterinary medicine with diverse etiologies.
- Current research highlights topical therapies as a promising avenue for pruritus management.
Purpose of the Study:
- To emphasize a systematic approach for diagnosing and treating pruritus in dogs.
- To underscore the importance of identifying and addressing primary causes of pruritus.
- To highlight the role of topical therapy in managing canine pruritus.
Main Methods:
- A systematic review of current literature on canine pruritus.
- Analysis of diagnostic strategies for identifying pruritus origins.
- Evaluation of various therapeutic interventions, including topical treatments.
Main Results:
- Pruritus management necessitates a thorough investigation into underlying causes.
- Successful treatment outcomes are significantly correlated with addressing primary etiologies.
- Topical therapies are emerging as a key component in multimodal pruritus treatment plans.
Conclusions:
- A systematic diagnostic process is crucial for effective pruritus treatment in dogs.
- Resolving primary causes is paramount for successful therapeutic outcomes.
- Targeting topical therapy offers a significant advancement in managing canine pruritus.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:22Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:26Cholinergic Antagonists: Therapeutic Uses
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...